Lv51
830 积分 2023-01-13 加入
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
54分钟前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
55分钟前
已完结
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
12天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
1个月前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
2个月前
已完结
肺结节诊治中国专家共识（2024年版）
2个月前
已完结
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial
3个月前
已完结
Janus激酶抑制剂治疗风湿免疫病的中国专家共识
3个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
6个月前
已完结
皖公网安备34019202002308
